Literature DB >> 11723099

Lipid lowering does not improve endothelial function in subjects with poorly controlled diabetes.

J Mansourati, L G Newman, S H Roman, A Travis, M Rafey, R A Phillips.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11723099     DOI： 10.2337/diacare.24.12.2152

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  4 in total

Review 1.  Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.

Authors:  Richard J Woodman; Gerard T Chew; Gerald F Watts
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  A pilot study of ezetimibe vs. atorvastatin for improving peripheral microvascular endothelial function in stable patients with type 2 diabetes mellitus.

Authors:  Seigo Sugiyama; Hideaki Jinnouchi; Kunio Hieshima; Noboru Kurinami; Tomoko Suzuki; Fumio Miyamoto; Keizo Kajiwara; Kunihiko Matsui; Tomio Jinnouchi
Journal:  Lipids Health Dis       Date:  2015-04-23       Impact factor: 3.876

Review 3.  Therapeutic interventions and oxidative stress in diabetes.

Authors:  Shilpa Rahangdale; Susie Yim Yeh; Atul Malhotra; Aristidis Veves
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

Review 4.  The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation.

Authors:  Paolo Gelosa; Mauro Cimino; Alice Pignieri; Elena Tremoli; Uliano Guerrini; Luigi Sironi
Journal:  Vasc Health Risk Manag       Date:  2007
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.